Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Meena S. Moran(Smilow Cancer Hospital), Jame Abraham(Cleveland Clinic), Rebecca Aft(Barnes-Jewish Hospital), Doreen M. Agnese(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Kimberly H. Allison(Cancer Institute (WIA)), Bethany Anderson(University of Wisconsin Carbone Cancer Center), Harold J. Burstein(Dana-Farber Brigham Cancer Center), Helen K. Chew(UC Davis Comprehensive Cancer Center), Chau T. Dang(Memorial Sloan Kettering Cancer Center), Anthony Elias(University of Colorado Cancer Center), Sharon H. Giordano(The University of Texas MD Anderson Cancer Center), Matthew P. Goetz(Fox Chase Cancer Center), Lori J. Goldstein(Fox Chase Cancer Center), Sara A. Hurvitz(University of Colorado Cancer Center), Steven J. Isakoff(Massachusetts General Hospital), Rachel C. Jankowitz(University of Pennsylvania), Sara H. Javid(Fred Hutch Cancer Center), Jairam Krishnamurthy(Susan Thompson Buffett Foundation), Marilyn Leitch(Southwestern Medical Center), Janice A. Lyons(Cleveland Clinic), Joanne Mortimer(City Of Hope National Medical Center), Sameer A. Patel(Fox Chase Cancer Center), Lori J. Pierce(University of Michigan), Laura H. Rosenberger(Cancer Institute (WIA)), Hope S. Rugo(UCSF Helen Diller Family Comprehensive Cancer Center), Amy M. Sitapati(University of California San Diego), Karen L. Smith(Sidney Kimmel Comprehensive Cancer Center), Mary Lou Smith(Research Advocacy Network), Hatem Soliman(Moffitt Cancer Center), Erica Stringer-Reasor(University of Colorado Cancer Center), Melinda L. Telli(Cancer Institute (WIA)), John H. Ward(University of Utah), Kari B. Wisinski(University of Wisconsin Carbone Cancer Center), Jessica Young, Jennifer L. Burns(Pancreatic Cancer Action Network), Rashmi Kumar(Pancreatic Cancer Action Network)
Cited by 961Open Access
Abstract
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.
Related Papers
No related papers found
Powered by citation graph analysis